Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: Support for nigral targeting in Parkinson's disease
| Autor: | Bartus, Raymond T., Brown, Lamar, Wilson, Alistair, Kruegel, Brian, Siffert, Joao, Johnson, Eugene M., Jr., Kordower, Jeffrey H., Herzog, Christopher D. |
|---|---|
| Zdroj: | In Neurobiology of Disease 2011 44(1):38-52 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect